ShuchiAnandMD

Nephrology • Stanford, CA

Physician

Join to view full profile

Dr. Anand is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Anand's full profile

Already have an account?

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-723-4000

Fax+1 650-721-1443

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Nephrology, 2009 - 2012
Brigham and Women's HospitalResidency, Internal Medicine, 2006 - 2009
Washington University in St. Louis School of MedicineClass of 2006

Certifications & Licensure

CA State Medical License 2010 - 2026
NY State Medical License 2009 - 2011
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Clinical Trials

Comparing Diuretic Strategies in Hospitalized Heart Failure Start of enrollment: 2023 Jul 01
Withdrawn
Phase 4
SARS-COV-2 Screening in Dialysis Facilities Start of enrollment: 2023 Feb 06
COMPLETED
NA
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

BPROAD - End of the Road for Debate on Systolic Blood-Pressure Goals in Type 2 Diabetes?
Shuchi Anand, Srinivasan Beddhu
The New England Journal of Medicine. 2025-03-27
The Sit Less, Interact and Move More (SLIMM-2) Trial: Protocol for a randomized control trial of a sedentary behavior intervention, resistance training and semaglutide...
Jesse C Christensen, Shuchi Anand, Glenn M Chertow, Kate Lyden, Amara Sarwal
Contemporary Clinical Trials. 2025-02-01
1 citations
Glucarpidase for Treatment of High-Dose Methotrexate Toxicity.
Shruti Gupta, Sarah Allison Kaunfer, Kevin L Chen, Julie-Alexia Dias, Anitha Vijayan
Blood. 2025-01-06

Journal Articles

Acute Kidney Injury Due to Diarrheal Illness Requiring Hospitalization: Data from the National Inpatient Sample
Shuchi Anand, Glenn M Chertow, Journal of General Internal Medicine

Press Mentions

Regular SARS-CoV-2 Testing in Hemodialysis Facilities Unacceptable to Most PatientsOctober 1st, 2024
SARS-CoV-2 Seroprevalence in Dialysis Patients 1-Year After COVID-19 Pandemic OnsetDecember 1st, 2021
J&J Coronavirus Vaccine Produces Low Antibody Response, Study FindsOctober 15th, 2021
Join now to see all

Grant Support

Pandemic preparedness for underserved persons in the US: Harnessing data from the RADx-UP consortium to assess public health tools for resource allocationSTANFORD UNIVERSITY2023–2025
Pandemic preparedness for underserved persons in the US: Harnessing data from the RADx-UP consortium to assess public health tools for resource allocationSTANFORD UNIVERSITY2023–2025
Pandemic preparedness for underserved persons in the US: Harnessing data from the RADx-UP consortium to assess public health tools for resource allocationSTANFORD UNIVERSITY2023–2025
Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney diseaseSTANFORD UNIVERSITY2021–2025
Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney diseaseSTANFORD UNIVERSITY2021–2025
Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney diseaseSTANFORD UNIVERSITY2021–2025
Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney diseaseSTANFORD UNIVERSITY2021–2025
Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney diseaseSTANFORD UNIVERSITY2021–2025
Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney diseaseSTANFORD UNIVERSITY2021–2025
Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney diseaseSTANFORD UNIVERSITY2021–2025